Capnia Inc, based in Foster City, CA, is a pioneering company at the forefront of improving newborn health care through their revolutionary technology. Their Cosense ETCOc monitor provides early and accurate measurement of hemolysis and neurotoxic risk, offering a non-invasive and rapid solution for identifying high-risk hemolytic cases in newborns.
Endorsed by the AAP as the gold standard for diagnosing hemolysis, Capnia's Cosense ETCOc monitor helps healthcare professionals manage jaundice more effectively by detecting and measuring the overproduction of unconjugated bilirubin, ultimately leading to improved outcomes and reduced costs in neonatal care.
Generated from the website